Showing results (241-250 of 270) with videos related to
Sort By:
Pageof 27
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigensRyan D Guest, Robert E Hawkins, Natalia Kirillova, et al.The Journal of Biological Chemistry|January 23, 1999
A common binding site on the microsomal triglyceride transfer protein for apolipoprotein B and protein disulfide isomeraseP Bradbury, C J Mann, S Köchl, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibodyA Mayer, E Tsiompanou, D O'Malley, et al.Cell Death & Disease|February 10, 2023
A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectorsAlessia Floerchinger, Jessica E Klein, Maximiliane S C Finkbeiner, et al.Scientific Reports|March 23, 2013
Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'Felix F Schumacher, Vishal A Sanchania, Berend Tolner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrugAstrid Mayer, Roslyn J Francis, Surinder K Sharma, et al.Nature Medicine|September 1, 1996
Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial libraryR H Begent, M J Verhaar, K A Chester, et al.Mabs|October 1, 2015
Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CAPaul W H I Parren, Dennis R Burton, Andrew Bradbury, et al.Cell|October 10, 1997
Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamineM Rubinstein, T J Phillips, J R Bunzow, et al.Mabs|December 18, 2014
Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014James W Larrick, Paul W H I Parren, James S Huston, et al.Pageof 27